Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 133 of 133 entries
View as:

To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06940336 Org: User:
Start: 09/30/25 End: 02/29/28 Due: 02/28/29

A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06500507 Org: User:
Start: 08/30/24 End: 01/31/27 Due: 01/31/28

Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT05950516 Org: User:
Start: 07/10/23 End: 01/22/25 Due: 01/22/26

A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05150405 Org: User:
Start: 10/19/21 End: 06/01/24 Due: 06/01/25

QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04326829 Org: User:
Start: 07/08/20 End: 07/31/23 Due: 07/31/24

Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06932094 Org: User:
Start: 05/31/25 End: 02/29/28 Due: 02/28/29

Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06837896 Org: User:
Start: 02/28/25 End: 12/31/26 Due: 12/31/27

A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05649761 Org: User:
Start: 05/29/19 End: 01/23/23 Due: 01/23/24